Preprint · OA
via OpenAlex
Influence of bone densitometry results on the treatment of osteoporosis.
N S Fitt, S. L. Mitchell, Ann Cranney, Karen Y. Gulenchyn, M Huang, Peter Tugwell
Europe PMC (PubMed Central) · 2001 · ▲ 54 citations
Abstract
BACKGROUND: Measurement of bone mineral density is widely used to diagnose osteoporosis. The objectives of this study are to determine how bone densitometry affects subsequent treatment of osteopenia and osteoporosis with either hormone replacement therapy or bisphosphonates and to examine clinical factors associated with starting either therapy after bone densitometry. METHODS: We conducted a prospective study involving women over 50 years of age who were referred to a tertiary care hospital for the first time to undergo bone density measurement using dual-energy x-ray absorptiometry (DXA). Baseline clinical data were collected through face-to-face interviews before the test. Subsequently, the scans were reviewed and categorized as showing no bone loss, osteopenia or osteoporosis, based on World Health Organization criteria. Three months after DXA, subjects were contacted by telephone to determine their understanding of the test results and any new treatments started or recommended since the scan. RESULTS: Of 383 women recruited at the time of their DXA, 335 (87.5%) completed the 3-month follow-up. Among those reached at follow-up, DXA results showed no bone loss in 119 (35.5%), osteopenia in 137 (40.9%) and osteoporosis in 79 (23.6%). The proportion of subjects with osteoporosis receiving either hormone replacement therapy or bisphosphonate therapy was 15.2% before the test, increasing to 63.3% after the scan. The following factors were independently associated with the initiation of either therapy: actual DXA result showing osteoporosis (odds ratio [OR] 7.2; 95% confidence interval [CI] 1.7-30.3), compared with a normal scan; subjects' perception that their scan showed bone loss (osteopenia, or osteoporosis) (OR 13.5; 95% CI 4.0-45.5) or that they were unclear about the results (OR 5.4; 95% CI 1.6-18.8), compared with the perception that the results were normal; and discussion of the DXA results with a physician (OR 5.5; 95% CI 1.9-16.0). INTERPRETATION: The proportion of women with osteoporosis receiving hormone replacement therapy or bisphosphonate therapy increases after diagnosis with densitometry. However, communication by physicians so that patients understand their test results is a critical component in the initiation of therapy after bone densitometry.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Fitt, N.S., Mitchell, S.L., Cranney, A., Gulenchyn, K.Y., Huang, M., & Tugwell, P. (2001). Influence of bone densitometry results on the treatment of osteoporosis. <em>Europe PMC (PubMed Central)</em>. https://openalex.org/W1860872053
Vancouver
Fitt NS, Mitchell SL, Cranney A, Gulenchyn KY, Huang M, Tugwell P. Influence of bone densitometry results on the treatment of osteoporosis. Europe PMC (PubMed Central). 2001.
BibTeX
@unpublished{n2001Influe,
title = {Influence of bone densitometry results on the treatment of osteoporosis.},
author = {N S Fitt and S. L. Mitchell and Ann Cranney and Karen Y. Gulenchyn and M Huang and Peter Tugwell},
journal = {Europe PMC (PubMed Central)},
year = {2001},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Modern hospital 2006
Citation only
QUANTITATIVE ULTRASOUND MEASUREMENT OF CALCANEUS BONE FOR THE ASSESSMENT OF THE OSTEOPOROSIS CHANGE WITH AGE IN ZHANJIANG CITY HEALTHY CROWD
Chinese Journal of Osteoporosis 2008
Citation only
Age-related bone mineral density,bone loss rate,prevalence of osteoporosis and reference database of women at multiple centers in China
Journal of Bone and Mineral Research 2015
Citation only
Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years
Uppsala University 2026
Open access · US-GOV
Patients With Long-stay at ICU: Factors and Evaluation (LIFE-ICU) - A Feasibility Study for a National Prospective Cohort Study
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
REGENERATIVE GENE THERAPY IN THE HYPOTHALAMUS PROLONGS FERTILITY IN FEMALE RATS
PubMed 2012
Preprint